Ginkgolide B stimulates signaling events in neutrophils and primes defense activities

Biochemical and Biophysical Research Communications

Volumn 335, Issue 4, 2005, Pages 1149-1154

  Lenoir, Monique ^a   Muntaner, Olivier ^a   Pedruzzi, Eric ^b   Roch Arveiller, Monique ^a   Tissot, Michèle ^a   Drieu, Katy ^c   Périanin, Axel ^a  

^a INSTITUT COCHIN   (France)

^b BICHAT HOSPITAL   (France)

^c Institut Henri Beaufour   (France)

Author keywords

EGb 761; Ginkgolide; MAP kinases; Migration; Neutrophil; Paf antagonist; Respiratory burst; ROS; Signaling

Indexed keywords

CALCIUM; CHEMOATTRACTANT; COMPLEMENT COMPONENT C5A; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GINKGO BILOBA EXTRACT; GINKGOLIDE B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; NEUTROPHIL; NONHUMAN; PLEURISY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RESPIRATORY BURST; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; GINKGOLIDES; HUMANS; IMMUNITY, NATURAL; LACTONES; MALE; NEUTROPHIL ACTIVATION; NEUTROPHILS; PLEURISY; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

GINKGO BILOBA;

EID: 24044515885     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.08.010     Document Type: Article

References (29)

1. F. DeFeudis, in: Elsevier (Ed.), Ginkgo biliba Extract (EGB 761): Pharmacological Activities and Clinical Applications, Paris, 1991.
2. Y. Christen, M.T. Droy-Lefaix, in: Elsevier (Ed.), Effects of Ginkgo Biloba Extract (EGB 761) on Aging and Age-related Disorders, Paris, 1995.
3. F. DeFeudis, in: Medical, U. (Ed.), Ginkgo biloba Extract (EGB 761): From Chemistry to the Clinic, Wiesbaden, 1998.
4. S.B. Braquet, M. Braquet, R.H. Bourgain, J.E. Taylor, A. Etienne, and K. Drieu BN 52021 and related compounds: a series of highly specific PAF-acether receptor antagonists isolated from Ginkgo biloba Blood Vessels 16 1985 559 572
5. S.B. Hwang, M.H. Lam, and M.N. Chang Specific binding of [3H]dihydrokadsurenone to rabbit platelet membranes and its inhibition by the receptor agonists and antagonists of platelet-activating factor J. Biol. Chem. 261 1986 13720 13726
6. E. Foldes-Filep, P. Braquet, and J. Filep Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes Biochem. Biophys. Res. Commun. 148 1987 1412 1417
7. K. Kurihara, A.J. Wardlaw, R. Moqbel, and A.B. Kay Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021 J. Allergy Clin. Immunol. 83 1989 83 90
8. Z.Y. Du, and X.Y. Li Effects of ginkgolides on interleukin-1, tumor necrosis factor-alpha and nitric oxide production by rat microglia stimulated with lipopolysaccharides in vitro Arzneimittelforschung 48 1998 1126 1130
9. S.J. Wang, and H.H. Chen Ginkgolide B, a constituent of Ginkgo biloba, facilitates glutamate exocytosis from rat hippocampal nerve terminals Eur. J. Pharmacol. 514 2005 141 149
10. M. Lenoir, E. Pedruzzi, S. Rais, K. Drieu, and A. Perianin Sensitization of neutrophil defense activities through activation of platelet-activating factor receptors by ginkgolide B, a bioactive component of the Ginkgo biloba extract EGB 761 Biochem. Pharmacol. 63 2002 1241 1249
11. S. Pietri, E. Maurelli, K. Drieu, and M. Culcasi Cardioprotective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761) J. Mol. Cell. Cardiol. 29 1997 733 742
12. 2+ indicators with greatly improved fluorescence properties J. Biol. Chem. 260 1985 3440 3450
13. A. Perianin, and R. Synderman Analysis of calcium homeostasis in activated human polymorphonuclear leukocytes. Evidence for two distinct mechanisms for lowering cytosolic calcium J. Biol. Chem. 264 1989 1005 1009
14. A. Perianin, C. Combadiere, E. Pedruzzi, B. Djerdjouri, and J. Hakim Staurosporine stimulates phospholipase D activation in human polymorphonuclear leukocytes FEBS Lett. 315 1993 33 37
15. A. Perianin, M. Roch-Arveiller, J.P. Giroud, and J. Hakim In vivo interaction of nonsteroidal anti-inflammatory drugs on the locomotion of neutrophils elicited by acute non-specific inflammations in the rat-effect of indomethacin, ibuprofen and flurbiprofen Biochem. Pharmacol. 33 1984 2239 2243
16. J.G. Bender, L.C. McPhail, and D.E. Van Epps Exposure of human neutrophils to chemotactic factors potentiates activation of the respiratory burst enzyme J. Immunol. 130 1983 2316 2323
17. M.B. Hallett, and D. Lloyds Neutrophil priming: the cellular signals that say 'amber' but not 'green' Immunol. Today 16 1995 264 268
18. A. Perianin, and R. Snyderman Mastoparan, a wasp venom peptide, identifies two discrete mechanisms for elevating cytosolic calcium and inositol trisphosphates in human polymorphonuclear leukocytes J. Immunol. 143 1989 1669 1673
19. 2+ concentrations of human neutrophils Biochem. J. 283 1992 499 505
20. Y. Kanaho, K. Takahashi, U. Tomita, T. Iiri, T. Katada, M. Ui, and Y. Nozawa A protein kinase C inhibitor, staurosporine, activates phospholipase D via a pertussis toxin-sensitive GTP-binding protein in rabbit peritoneal neutrophils J. Biol. Chem. 267 1992 23554 23559
21. M. Lenoir, B. Djerdjouri, and A. Perianin Stroma cell-derived factor 1alpha mediates desensitization of human neutrophil respiratory burst in synovial fluid from rheumatoid arthritic patients J. Immunol. 172 2004 7136 7143
22. H. Ali, R.M. Richardson, B. Haribabu, and R. Snyderman Chemoattractant receptor cross-desensitization J. Biol. Chem. 274 1999 6027 6030
23. I. Ishii, E. Saito, T. Izumi, M. Ui, and T. Shimizu Agonist-induced sequestration, recycling, and resensitization of platelet-activating factor receptor. Role of cytoplasmic tail phosphorylation in each process J. Biol. Chem. 273 1998 9878 9885
24. J.T. O'Flaherty, J.R. Surles, J. Redman, D. Jacobson, C. Piantadosi, and R.L. Wykle Binding and metabolism of platelet-activating factor by human neutrophils J. Clin. Invest. 78 1986 381 388
25. D.S. Ng, and K. Wong GTP regulation of platelet-activating factor binding to human neutrophil membranes Biochem. Biophys. Res. Commun. 141 1986 353 359
26. J.F. Dhainaut, A. Tenaillon, Y. Le Tulzo, B. Schlemmer, J.P. Solet, M. Wolff, L. Holzapfel, F. Zeni, D. Dreyfuss, and J.P. Mira Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo- controlled, multicenter clinical trial. BN 52021 Sepsis Study Group Crit. Care Med. 22 1994 1720 1728
27. J.F. Dhainaut, A. Tenaillon, M. Hemmer, P. Damas, Y. Le Tulzo, P. Radermacher, M.D. Schaller, J.P. Sollet, M. Wolff, L. Holzapfel, F. Zeni, J.M. Vedrinne, F. de Vathaire, M.L. Gourlay, P. Guinot, and J.P. Mira Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group [see comments] Crit. Care Med. 26 1998 1963 1971
28. C. Natanson, C.J. Esposito, and S.M. Banks The sirens' songs of confirmatory sepsis trials: selection bias and sampling error [editorial; comment] Crit. Care Med. 26 1998 1927 1931
29. M. Damon, C. Le Doucen, F. Michel, and A. Craste de Paulet Un piégeur de radicaux libres: L'extrait de Gingko biloba Diététique et Médécine. 3 1987 1 4